 | • レポートコード：20QY06-05527 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗体のグローバル市場について種類別（IgM、IgG、IgA、その他）、用途別（治療、研究、診断）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗体市場の概要 ・世界の主要地域別抗体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗体市場規模2015-2026：種類別（IgM、IgG、IgA、その他） ・世界の抗体市場規模2015-2026：用途別（治療、研究、診断） ・抗体の北米市場規模2015-2020 ・抗体のヨーロッパ市場規模2015-2020 ・抗体の中国市場規模2015-2020 ・抗体の日本市場規模2015-2020 ・抗体の東南アジア市場規模2015-2020 ・抗体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Johnson & Johnson、Merck、Novartis、AbbVie、Amgen、Pfizer、Bayer、Lilly、Bristol-Myers Squibb、GlaxoSmithKline、Biogen、AstraZeneca、Sanofi、Alexion Pharmaceuticals、Seattle Genetics） ・抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗体の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Antibody Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Antibody market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibody market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antibody industry.
Based on our recent survey, we have several different scenarios about the Antibody YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 8166.8 million in 2019. The market size of Antibody will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Antibody market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Antibody market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Antibody market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Antibody market. The report also includes nautical information, where it shows Antibody market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Antibody market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Antibody market.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.
In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%
In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.
The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.
Geographical Analysis:
Based on region, the global Antibody market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Antibody market are
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Antibody market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Antibody market.
• The market share of the global Antibody market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Antibody market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Antibody market.
1 Antibody Market Overview
1.1 Antibody Product Scope
1.2 Antibody Segment by Type
1.2.1 Global Antibody Sales by Type (2020-2026)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Segment by Application
1.3.1 Global Antibody Sales Comparison by Application (2020-2026)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Antibody Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antibody Sales Growth Rate (2015-2026)
1.4.2 Global Antibody Revenue and Growth Rate (2015-2026)
1.4.3 Global Antibody Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Antibody Industry Impact
1.5.1 How the Covid-19 is Affecting the Antibody Industry
1.5.1.1 Antibody Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Antibody Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Antibody Players to Combat Covid-19 Impact
2 Antibody Estimate and Forecast by Region
2.1 Global Antibody Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antibody Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antibody Sales Market Share by Region (2015-2020)
2.2.2 Global Antibody Revenue Market Share by Region (2015-2020)
2.3 Global Antibody Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antibody Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antibody Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antibody Estimates and Projections (2015-2026)
2.4.2 Europe Antibody Estimates and Projections (2015-2026)
2.4.3 China Antibody Estimates and Projections (2015-2026)
2.4.4 Japan Antibody Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antibody Estimates and Projections (2015-2026)
2.4.6 India Antibody Estimates and Projections (2015-2026)
3 Global Antibody Competition Landscape by Players
3.1 Global Top Antibody Players by Sales (2015-2020)
3.2 Global Top Antibody Players by Revenue (2015-2020)
3.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody as of 2019)
3.4 Global Antibody Average Price by Company (2015-2020)
3.5 Manufacturers Antibody Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antibody Players (Opinion Leaders)
4 Global Antibody Market Size by Type
4.1 Global Antibody Historic Market Review by Type (2015-2020)
4.1.1 Global Antibody Sales Market Share by Type (2015-2020)
4.1.2 Global Antibody Revenue Market Share by Type (2015-2020)
4.1.3 Global Antibody Price by Type (2014-2020)
4.2 Global Antibody Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody Revenue Forecast by Type (2021-2026)
4.2.3 Global Antibody Price Forecast by Type (2021-2026)
5 Global Antibody Market Size by Application
5.1 Global Antibody Historic Market Review by Application (2015-2020)
5.1.1 Global Antibody Sales Market Share by Application (2015-2020)
5.1.2 Global Antibody Revenue Market Share by Application (2015-2020)
5.1.3 Global Antibody Price by Application (2015-2020)
5.2 Global Antibody Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody Price Forecast by Application (2021-2026)
3 North America Antibody Market Facts & Figures
3.2 North America Antibody Sales Market Share by Company (2015-2020)
3.3 North America Antibody Sales Market Share by Type (2015-2020)
3.4 North America Antibody Sales Market Share by Application (2015-2020)
4 Europe Antibody Market Facts & Figures
4.2 Europe Antibody Sales Market Share by Company (2015-2020)
4.3 Europe Antibody Sales Market Share by Type (2015-2020)
4.4 Europe Antibody Sales Market Share by Application (2015-2020)
5 China Antibody Market Facts & Figures
5.2 China Antibody Sales Market Share by Company (2015-2020)
5.3 China Antibody Sales Market Share by Type (2015-2020)
5.4 China Antibody Sales Market Share by Application (2015-2020)
6 Japan Antibody Market Facts & Figures
6.2 Japan Antibody Sales Market Share by Company (2015-2020)
6.3 Japan Antibody Sales Market Share by Type (2015-2020)
6.4 Japan Antibody Sales Market Share by Application (2015-2020)
7 Southeast Asia Antibody Market Facts & Figures
7.2 Southeast Asia Antibody Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Antibody Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Antibody Sales Market Share by Application (2015-2020)
8 India Antibody Market Facts & Figures
8.2 India Antibody Sales Market Share by Company (2015-2020)
8.3 India Antibody Sales Market Share by Type (2015-2020)
8.4 India Antibody Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antibody Business
12.1 Roche
12.1.1 Roche Antibody Corporation Information
12.1.2 Roche Antibody Business Overview and Total Revenue
12.1.3 Roche Antibody Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Antibody Products Offered
12.1.5 Roche Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Antibody Corporation Information
12.2.2 Johnson & Johnson Antibody Business Overview and Total Revenue
12.2.3 Johnson & Johnson Antibody Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Antibody Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Antibody Corporation Information
12.3.2 Merck Antibody Business Overview and Total Revenue
12.3.3 Merck Antibody Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Antibody Products Offered
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Antibody Corporation Information
12.4.2 Novartis Antibody Business Overview and Total Revenue
12.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Antibody Products Offered
12.4.5 Novartis Recent Development
12.5 AbbVie
12.5.1 AbbVie Antibody Corporation Information
12.5.2 AbbVie Antibody Business Overview and Total Revenue
12.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AbbVie Antibody Products Offered
12.5.5 AbbVie Recent Development
12.6 Amgen
12.6.1 Amgen Antibody Corporation Information
12.6.2 Amgen Antibody Business Overview and Total Revenue
12.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Amgen Antibody Products Offered
12.6.5 Amgen Recent Development
12.7 Pfizer
12.7.1 Pfizer Antibody Corporation Information
12.7.2 Pfizer Antibody Business Overview and Total Revenue
12.7.3 Pfizer Antibody Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Antibody Products Offered
12.7.5 Pfizer Recent Development
12.8 Bayer
12.8.1 Bayer Antibody Corporation Information
12.8.2 Bayer Antibody Business Overview and Total Revenue
12.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bayer Antibody Products Offered
12.8.5 Bayer Recent Development
12.9 Lilly
12.9.1 Lilly Antibody Corporation Information
12.9.2 Lilly Antibody Business Overview and Total Revenue
12.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Lilly Antibody Products Offered
12.9.5 Lilly Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Antibody Corporation Information
12.10.2 Bristol-Myers Squibb Antibody Business Overview and Total Revenue
12.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bristol-Myers Squibb Antibody Products Offered
12.10.5 Bristol-Myers Squibb Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Antibody Corporation Information
12.11.2 GlaxoSmithKline Antibody Business Overview and Total Revenue
12.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Antibody Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Biogen
12.12.1 Biogen Antibody Corporation Information
12.12.2 Biogen Antibody Business Overview and Total Revenue
12.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Biogen Antibody Products Offered
12.12.5 Biogen Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Antibody Corporation Information
12.13.2 AstraZeneca Antibody Business Overview and Total Revenue
12.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2015-2020)
12.13.4 AstraZeneca Antibody Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Sanofi
12.14.1 Sanofi Antibody Corporation Information
12.14.2 Sanofi Antibody Business Overview and Total Revenue
12.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Sanofi Antibody Products Offered
12.14.5 Sanofi Recent Development
12.15 Alexion Pharmaceuticals
12.15.1 Alexion Pharmaceuticals Antibody Corporation Information
12.15.2 Alexion Pharmaceuticals Antibody Business Overview and Total Revenue
12.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Alexion Pharmaceuticals Antibody Products Offered
12.15.5 Alexion Pharmaceuticals Recent Development
12.16 Seattle Genetics
12.16.1 Seattle Genetics Antibody Corporation Information
12.16.2 Seattle Genetics Antibody Business Overview and Total Revenue
12.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Seattle Genetics Antibody Products Offered
12.16.5 Seattle Genetics Recent Development
13 Antibody Manufacturing Cost Analysis
13.1 Antibody Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody
13.4 Antibody Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody Distributors List
14.3 Antibody Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antibody Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Antibody Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Antibody Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Antibody Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Antibody Players to Combat Covid-19 Impact
Table 8. Global Market Antibody Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Antibody Sales (MT) by Region (2015-2020)
Table 10. Global Antibody Sales Market Share by Region (2015-2020)
Table 11. Global Antibody Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Antibody Revenue Share by Region (2015-2020)
Table 13. Global Antibody Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Antibody Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Antibody Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Antibody Revenue Share Forecast by Region (2021-2026)
Table 17. Global Antibody (MT) of Key Companies (2015-2020)
Table 18. Global Antibody Sales Share by Company (2015-2020)
Table 19. Global Antibody Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Antibody Revenue Share by Company (2015-2020)
Table 21. Global Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody as of 2019)
Table 22. Global Antibody Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Antibody Manufacturing Sites and Area Served
Table 24. Manufacturers Antibody Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Antibody Players
Table 27. Global Antibody Sales (MT) by Type (2015-2020)
Table 28. Global Antibody Sales Share by Type (2015-2020)
Table 29. Global Antibody Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Antibody Price (MT) by Type (2015-2020)
Table 31. Global Antibody Sales Share by Type (2021-2026)
Table 32. Global Antibody Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Antibody Revenue Share by Type (2021-2026)
Table 34. Global Antibody Price (MT) by Type (2021-2026)
Table 35. Global Antibody Sales (MT) by Application (2015-2020)
Table 36. Global Antibody Sales Share by Application (2015-2020)
Table 37. Global Antibody Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Antibody Price (MT) by Application (2015-2020)
Table 39. Global Antibody Sales (MT) by Application (2021-2026)
Table 40. Global Antibody Sales Share by Application (2021-2026)
Table 41. Global Antibody Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Antibody Revenue Share by Application (2021-2026)
Table 43. Global Antibody Price (MT) by Application (2021-2026)
Table 44. United States Antibody Sales (MT) by Company (2015-2020)
Table 45. United States Antibody Sales Market Share by Company (2015-2020)
Table 46. United States Antibody Sales (MT) by Type (2015-2020)
Table 47. United States Antibody Sales Market Share by Type (2015-2020)
Table 48. United States Antibody Sales (MT) by Application (2015-2020)
Table 49. United States Antibody Sales Market Share by Application (2015-2020)
Table 50. Europe Antibody Sales (MT) by Company (2015-2020)
Table 51. Europe Antibody Sales Market Share by Company (2015-2020)
Table 52. Europe Antibody Sales (MT) by Type (2015-2020)
Table 53. Europe Antibody Sales Market Share by Type (2015-2020)
Table 54. Europe Antibody Sales (MT) by Application (2015-2020)
Table 55. Europe Antibody Sales Market Share by Type (2015-2020)
Table 56. China Antibody Sales (MT) by Company (2015-2020)
Table 57. China Antibody Sales Market Share by Company (2015-2020)
Table 58. China Antibody Sales (MT) by Type (2015-2020)
Table 59. China Antibody Sales Market Share by Type (2015-2020)
Table 60. China Antibody Sales (MT) by Application (2015-2020)
Table 61. China Antibody Sales Market Share by Application (2015-2020)
Table 62. Japan Antibody Sales (MT) by Company (2015-2020)
Table 63. Japan Antibody Sales Market Share by Company (2015-2020)
Table 64. Japan Antibody Sales (MT) by Type (2015-2020)
Table 65. Japan Antibody Sales Market Share by Type (2015-2020)
Table 66. Japan Antibody Sales (MT) by Application (2015-2020)
Table 67. Japan Antibody Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Antibody Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Antibody Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Antibody Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Antibody Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Antibody Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Antibody Sales Market Share by Application (2015-2020)
Table 74. India Antibody Sales (MT) by Company (2015-2020)
Table 75. India Antibody Sales Market Share by Company (2015-2020)
Table 76. India Antibody Sales (MT) by Type (2015-2020)
Table 77. India Antibody Sales Market Share by Type (2015-2020)
Table 78. India Antibody Sales (MT) by Application (2015-2020)
Table 79. India Antibody Sales Market Share by Application (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Roche Antibody Product
Table 84. Roche Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Antibody Product
Table 89. Johnson & Johnson Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Merck Antibody Product
Table 94. Merck Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novartis Antibody Product
Table 99. Novartis Recent Development
Table 100. AbbVie Corporation Information
Table 101. AbbVie Description and Business Overview
Table 102. AbbVie Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. AbbVie Antibody Product
Table 104. AbbVie Recent Development
Table 105. Amgen Corporation Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Amgen Antibody Product
Table 109. Amgen Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Pfizer Antibody Product
Table 114. Pfizer Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Bayer Description and Business Overview
Table 118. Bayer Antibody Product
Table 119. Bayer Recent Development
Table 120. Lilly Corporation Information
Table 121. Lilly Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Lilly Description and Business Overview
Table 123. Lilly Antibody Product
Table 124. Lilly Recent Development
Table 125. Bristol-Myers Squibb Corporation Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Bristol-Myers Squibb Antibody Product
Table 129. Bristol-Myers Squibb Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. GlaxoSmithKline Antibody Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Biogen Corporation Information
Table 136. Biogen Description and Business Overview
Table 137. Biogen Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Biogen Antibody Product
Table 139. Biogen Recent Development
Table 140. AstraZeneca Corporation Information
Table 141. AstraZeneca Description and Business Overview
Table 142. AstraZeneca Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. AstraZeneca Antibody Product
Table 144. AstraZeneca Recent Development
Table 145. Sanofi Corporation Information
Table 146. Sanofi Description and Business Overview
Table 147. Sanofi Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Sanofi Antibody Product
Table 149. Sanofi Recent Development
Table 150. Alexion Pharmaceuticals Corporation Information
Table 151. Alexion Pharmaceuticals Description and Business Overview
Table 152. Alexion Pharmaceuticals Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Alexion Pharmaceuticals Antibody Product
Table 154. Alexion Pharmaceuticals Recent Development
Table . Seattle Genetics Corporation Information
Table . Seattle Genetics Description and Business Overview
Table . Seattle Genetics Antibody Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Seattle Genetics Antibody Product
Table . Seattle Genetics Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Antibody Distributors List
Table 163. Antibody Customers List
Table 164. Market Key Trends
Table 165. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 166. Key Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Product Picture
Figure 2. Global Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibody Market Share by Application in 2020 & 2026
Figure 6. Therapeutic Examples
Figure 7. Research Examples
Figure 8. Diagnostic Examples
Figure 9. Global Antibody Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Antibody Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Antibody Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Antibody Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Antibody Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Antibody Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Antibody Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Antibody Players Market Share by Revenue in Antibody 2015 & 2019
Figure 27. Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Antibody Revenue Share by Type (2015-2020)
Figure 29. Global Antibody Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Antibody Revenue Share by Application (2015-2020)
Figure 31. Global Antibody Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Antibody Sales Market Share by Type in 2019
Figure 33. United States Antibody Sales Market Share by Type in 2019
Figure 34. Europe Antibody Sales Market Share by Company in 2019
Figure 35. Europe Antibody Sales Market Share by Type in 2019
Figure 36. Europe Antibody Sales Market Share by Application in 2019
Figure 37. China Antibody Sales Market Share by Company in 2019
Figure 38. China Antibody Sales Market Share by Type in 2019
Figure 39. China Antibody Sales Market Share by Application in 2019
Figure 40. Japan Antibody Sales Market Share by Company in 2019
Figure 41. Japan Antibody Sales Market Share by Type in 2019
Figure 42. Japan Antibody Sales Market Share by Application in 2019
Figure 43. Southeast Asia Antibody Sales Market Share by Company in 2019
Figure 44. Southeast Asia Antibody Sales Market Share by Type in 2019
Figure 45. Southeast Asia Antibody Sales Market Share by Application in 2019
Figure 46. India Antibody Sales Market Share by Company in 2019
Figure 47. India Antibody Sales Market Share by Type in 2019
Figure 48. India Antibody Sales Market Share by Application in 2019
Figure 49. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Alexion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Antibody
Figure 67. Manufacturing Process Analysis of Antibody
Figure 68. Antibody Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
キメラ抗体の世界市場レポート2020 Market Analysis and Insights: Global Chimeric Antibody Market The global Chimeric Antibody market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Chimeric Antibody Scope and Market Size The global Chimeric Antib…- モノクローナル抗体診断試薬の世界市場レポート2020 A recently published report by QY Research titled Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistica…
- HER2抗体の世界市場レポート2020 Market Analysis and Insights: Global HER2 Antibody Market The global HER2 Antibody market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global HER2 Antibody Scope and Market Size The global HER2 Antibody market is se…
- 抗体薬物複合体の世界市場レポート2020 Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…
- キメラ抗体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chimeric Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chimeric Antibody market re…